WebJun 1, 2024 · This article presents datasets associated with the research article entitled “Intravitreal gene therapy protects against retinal dysfunction and degeneration in sheep with CLN5 Batten disease” (Murray et al., ).The neuronal ceroid lipofuscinoses (NCL; Batten disease) are a group of fatal inherited diseases caused by mutations in a number … WebFeb 26, 2015 · The heterozygous unaffected sheep recorded at the same age as the CLN5 −/− Batten disease affected sheep presented electrophysiological signatures that were much more similar to normal sheep than to CLN5 −/− Batten disease affected sheep. The observation of reduced slow-wave amplitudes during non-REM sleep can be interpreted …
Large animal models of rare genetic disorders: sheep as phenotypically ...
WebDec 30, 2024 · Additionally, proteomic analyses of urine from 3 CLN5-affected sheep and 13 CLN6-affected sheep were compared with seven normal control sheep (Tables S2 and S3). The volcano plot in Figure 1A summarizes the alterations found in the urinary proteome of patients with CLN2 disease and the CLN5 and CLN6 sheep models. The CLN5 profile … WebApr 1, 2024 · The existing knowledge on CLN5 biology stems from studies using several model organisms, including mice, sheep, cattle, dogs, social amoeba and cell cultures. … crypto fireblocks
Treatment Groups and Current Clinical Status of Treated Sheep
WebSep 1, 2005 · In CLN5 disease the engineered Cln5 -/mouse model and spontaneous models occurring in the Border Collie dog, the Borderdale sheep, and Devon cattle (Melville et al., 2005; Houweling et al., 2006 ... WebMay 30, 2024 · Affected sheep share the clinical and pathological features of the human disease, including retinal degeneration. Electroretinography (ERG) was employed to characterise the physiological changes in the degenerating retina of CLN5 and CLN6 forms of ovine NCL. ERGs were performed every two months from 3 to 17 months of age in 11 … Web1. A method to deliver acid beta glucosidase to the central nervous system in a subject having Gaucher disease, comprising: administering a recombinant AAV4 or AAV5 viral vector comprising a transgene encoding acid beta glucosidase to at least one ventricle of the brain selected from the group consisting of a lateral ventricle and the fourth ventricle by … crypto fire